Natural killer (NK) cells belong to the first line of host defense against infection and cancer. Cytokines, including interleukin-15 (IL-15), critically regulate NK cell activity, resulting in recognition and direct killing of transformed and infected target cells. NK cells have to adapt and respond in inflamed and often hypoxic areas.
View Article and Find Full Text PDFThe role of norepinephrine in regulating brainstem seizures has been well documented. These seizures are characterized by running/bouncing clonus and tonic extensor convulsions. Evidence for noradrenergic regulation of brainstem seizures comes partially from studies with genetic models of epilepsy which are characterized by innate noradrenergic deficits and from selective lesioning of noradrenergic neurons and/or pathways.
View Article and Find Full Text PDFPharmacological and neurochemical evidence indicates that brain noradrenergic systems play an important role in the determination of audiogenic seizure severity in genetically epilepsy-prone rats (GEPRs). In earlier studies, intracerebroventricular (ICV) injections of norepinephrine suppressed convulsions in a now extinct moderate seizure GEPR colony. Also, ICV noradrenergic agonists are known to produce dose-related anticonvulsant effects in the extant moderate seizure GEPRs (GEPR-3s).
View Article and Find Full Text PDFSeizure facilitation has been proposed as a possible adverse effect of dietary consumption of aspartame. The conversion of this sweetener to phenylalanine and aspartate in the gastrointestinal tract, and subsequent absorption, elevates plasma levels of these two amino acids. Absorbed phenylalanine competes with other large neutral amino acids, including tyrosine and tryptophan, for transport into brain.
View Article and Find Full Text PDFIn order to investigate the mechanism of action of anticonvulsant drugs, we examined the effects of carbamazepine (CBZ) and antiepilepsirine (AE) on convulsions and on brain biogenic amines in genetically epilepsy-prone rats (GEPR). AE was an effective anticonvulsant in moderate seizure GEPR (GEPR-3, ED50 = 65.5 mg/kg) and in severe seizure GEPR (GEPR-9, ED50 = 68.
View Article and Find Full Text PDF